Eosinophil Cationic Protein as a Marker for Tacrolimus Treatment in Eye Allergies
Author Information
Author(s): Wakamatsu Tais Hitomi, Tanaka Mari, Satake Yoshiyuki, Dogru Murat, Fukagawa Kazumi, Igarashi Ayako, Fujishima Hiroshi
Primary Institution: Keio University School of Medicine
Hypothesis
Does tacrolimus eye drops effectively reduce symptoms and eosinophil levels in patients with atopic keratoconjunctivitis?
Conclusion
Tacrolimus eye drops significantly reduced symptoms of atopic keratoconjunctivitis and correlated well with eosinophil levels in tears.
Supporting Evidence
- Post-treatment tear ECP levels were significantly reduced compared to pre-treatment levels.
- Clinical corneal scores improved significantly after one month of treatment.
- Strong positive correlations were observed between ECP values and clinical signs.
Takeaway
This study shows that using tacrolimus eye drops can help people with a specific eye allergy feel better and have fewer eosinophils in their tears.
Methodology
Nine patients with atopic keratoconjunctivitis were treated with 0.1% tacrolimus eye drops for one month, and changes in clinical signs and eosinophil levels in tears were measured.
Limitations
The study involved a small sample size and a short treatment duration.
Participant Demographics
8 males and 1 female, aged 6 to 44 years, mean age 16.9 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website